An EORTC-ECSG phase II study of vinorelbine in patients with recurrent and/or metastatic squamous cell carcinoma of the head and neck
Open Access
- 1 October 1998
- journal article
- clinical trial
- Published by Elsevier in Annals of Oncology
- Vol. 9 (10) , 1103-1107
- https://doi.org/10.1023/a:1008446706578
Abstract
No abstract availableKeywords
This publication has 19 references indexed in Scilit:
- Randomized comparison of cisplatin, methotrexate, bleomycin and vincristine (CABO) versus cisplatin and 5-fluorouracil (CF) versus cisplatin (C) in recurrent or metastatic squamous cell carcinoma of the head and neckAnnals of Oncology, 1994
- Vinorelbine in pre-treated advanced head & neck squamous cell carcinomaInvestigational New Drugs, 1994
- A pilot study of vinorelbine on a weekly schedule in recurrent and/or metastatic squamous cell carcinoma of the head and neckEuropean Journal Of Cancer, 1993
- Head and Neck CancerNew England Journal of Medicine, 1993
- Southwest Oncology Group standard response criteria, endpoint definitions and toxicity criteriaInvestigational New Drugs, 1992
- Cancer statistics, 1992CA: A Cancer Journal for Clinicians, 1992
- Frequency and Sites of Distant Metastases in Head and Neck Squamous Cell Carcinoma: An Analysis of 101 Cases at AutopsyJAMA Otolaryngology–Head & Neck Surgery, 1987
- Chemotherapy in Head and Neck CancerNew England Journal of Medicine, 1983
- Reporting results of cancer treatmentCancer, 1981
- Comparative pharmacokinetics of vindesine, vincristine and vinblastine in patients with cancerCancer Treatment Reviews, 1980